Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention

20031,162 citationsJournal Article

Authors

A. Michael Lincoff · Cleveland Clinic

John A. Bittl · Munroe Regional Medical Center

Robert A. Harrington · Clinical Research Institute

Frederick Feit · New York University

Neal S. Kleiman

J. Daniel Jackman

Ian J. Sarembock · University of Virginia Health System

David J. Cohen ·

Abstract

Bivalirudin with provisional Gp IIb/IIIa blockade is statistically not inferior to heparin plus planned Gp IIb/IIIa blockade during contemporary PCI with regard to suppression of acute ischemic end points and is associated with less bleeding.

Topics & Keywords

Acute Myocardial Infarction Research Heparin-Induced Thrombocytopenia and Thrombosis Venous Thromboembolism Diagnosis and Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA

Volume 289, Issue 7, pp. 853-853

DOI: 10.1001/jama.289.7.853

Field-Weighted Citation Impact: 57.64